These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1424668)

  • 1. Recurrence of microbial keratitis concomitant with antiinflammatory treatment in an animal model.
    Gritz DC; Kwitko S; Trousdale MD; Gonzalez VH; McDonnell PJ
    Cornea; 1992 Sep; 11(5):404-8. PubMed ID: 1424668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
    Engel LS; Callegan MC; Hobden JA; Reidy JJ; Hill JM; O'Callaghan RJ
    Curr Eye Res; 1995 Mar; 14(3):229-34. PubMed ID: 7796606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of tobramycin-soaked collagen shields vs tobramycin eyedrop loading dose for sustained treatment of experimental Pseudomonas aeruginosa-induced keratitis in rabbits.
    Assil KK; Zarnegar SR; Fouraker BD; Schanzlin DJ
    Am J Ophthalmol; 1992 Apr; 113(4):418-23. PubMed ID: 1558116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobramycin liposomes. Single subconjunctival therapy of pseudomonal keratitis.
    Assil KK; Frucht-Perry J; Ziegler E; Schanzlin DJ; Schneiderman T; Weinreb RN
    Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3216-20. PubMed ID: 1748553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Lauffenburger MD; Cohen KL
    Cornea; 1993 Nov; 12(6):517-21. PubMed ID: 8261784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobramycin iontophoresis into corneas infected with drug-resistant Pseudomonas aeruginosa.
    Hobden JA; O'Callaghan RJ; Hill JM; Reidy JJ; Rootman DS; Thompson HW
    Curr Eye Res; 1989 Nov; 8(11):1163-9. PubMed ID: 2515036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin-enmeshed tobramycin liposomes: single application topical therapy of Pseudomonas keratitis.
    Frucht-Perry J; Assil KK; Ziegler E; Douglas H; Brown SI; Schanzlin DJ; Weinreb RN
    Cornea; 1992 Sep; 11(5):393-7. PubMed ID: 1424666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rabbit Streptococcus pneumoniae keratitis model and topical therapy.
    Guzek JP; Cline DJ; Row PK; Wessels IF; Beeve S; Ispirescu S; Aprecio RM; Kettering JD; Gano DL; Nelson GM
    Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2012-7. PubMed ID: 9761279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model.
    Gritz DC; McDonnell PJ; Lee TY; Tang-Liu D; Hubbard BB; Gwon A
    Cornea; 1992 Mar; 11(2):143-7. PubMed ID: 1582217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of topical ceftazidime on pseudomonas keratitis in rabbits.
    Kremer I; Robinson A; Braffman M; Drucker M; Goldenfeld M; Samra Z; Myszne-Daye N; Gaton D; Savir H
    Cornea; 1994 Jul; 13(4):360-3. PubMed ID: 7924338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
    Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis.
    McCormick C; Caballero A; Tang A; Balzli C; Song J; O'Callaghan R
    Curr Med Res Opin; 2008 Jun; 24(6):1569-75. PubMed ID: 18423106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of an improved combination therapy for experimental Staphylococcus aureus keratitis.
    Balzli CL; McCormick CC; Caballero AR; Tang A; O'Callaghan RJ
    Adv Ther; 2010 Dec; 27(12):933-40. PubMed ID: 21046494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic considerations in the treatment of bacterial keratitis.
    Callegan MC; O'Callaghan RJ; Hill JM
    Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental Pseudomonas keratitis.
    Silbiger J; Stern GA
    Ophthalmology; 1992 Jun; 99(6):889-92. PubMed ID: 1630778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical anti-inflammatory agents in an animal model of microbial keratitis.
    Gritz DC; Lee TY; Kwitko S; McDonnell PJ
    Arch Ophthalmol; 1990 Jul; 108(7):1001-5. PubMed ID: 2369336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory therapy and outcome in a guinea pig model of Pseudomonas keratitis.
    Ohadi C; Litwin KL; Moreira H; Kwitko S; Gauderman WJ; Gritz DC; Gwon A; Jones R; McDonnell PJ
    Cornea; 1992 Sep; 11(5):398-403. PubMed ID: 1424667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nitric oxide synthase inhibition in experimental Pseudomonas keratitis in rabbits.
    Er H; Turkoz Y; Ozerol IH; Uzmez E
    Eur J Ophthalmol; 1998; 8(3):137-41. PubMed ID: 9793765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.